Oxford Asset Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Oxford Asset Management’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-48,791	Closed	-$1.76M	–	896
2016 Q3	$1.76M	Buy	+48,791	New	+$1.05M	0.05%	424
2016 Q1	–	Sell	-93,893	Closed	-$3.3M	–	930
2015 Q4	$3.3M	Buy	93,893 +72,748	+344%	+$4.69M	0.08%	283
2015 Q3	$1.94M	Buy	+21,145	New	+$1.83M	0.06%	293
2013 Q4	–	Sell	-35,115	Closed	-$2.13M	–	816
2013 Q3	$2.13M	Sell	35,115 -34,278	-49%	-$2.43M	0.05%	437
2013 Q2	$4.65M	Buy	+69,393	New	+$3.12M	0.13%	259

Other funds holding CLVS

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Oxford Asset Management's CLVS Position: Q4 2016 in Review

Oxford Asset Management sold out of Clovis Oncology, Inc. (CLVS) in Q4 2016, closing a stake of 48,791 shares — an estimated $1.76M sold.

Oxford Asset Management first reported a position in CLVS in Q2 2013 and held it in 5 quarters. The position peaked at $4.65M in Q2 2013. 167 funds tracked by Wall St. Rank hold CLVS as of Q4 2016.

Oxford Asset Management reported no remaining Clovis Oncology, Inc. position as of Q4 2016 after selling out during the quarter.
Oxford Asset Management sold 48,791 Clovis Oncology, Inc. shares in Q4 2016, an estimated $1.76M.
Oxford Asset Management first reported a position in Clovis Oncology, Inc. in Q2 2013 and held it in 5 quarters.
Oxford Asset Management's Clovis Oncology, Inc. position peaked at $4.65M in Q2 2013.
167 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2016.

Based on Oxford Asset Management's 13F filing for Q4 2016, filed 9 Feb 2017.